20 South Sarah Street St. Louis, MO 63108 314-615-6355 info@biogenerator.org


BioGenerator News

BioGenerator and Synchrony Bio lead initial financing for Readout, a Digital Health Startup

Jun 13, 2019

Readout adds veteran executive leadership to its management team ST. LOUIS – Readout, an early-stage digital health company, announced completion of its initial funding round, led by BioGenerator, the investment […]

Read More

BioGenerator Company Adarza BioSystems Reaches Commercialization Stage, Launches ZIVA Platform

May 02, 2019

Adarza BioSystems to reveal ZIVA platform at AAI 2019: a fully automated protein multiplex detection system ST. LOUIS (May 2, 2019) — Biotech startup Adarza Biosystems, Inc. announced today that […]

Read More

BioGenerator Company Canopy Biosciences Raises Series B Led By Ampersand, Acquires Zellkraftwerk

Apr 30, 2019

Press release:  https://canopybiosciences.com/news/canopy-biosciences-acquires-zellkraftwerk-gmbh/   Acquisition gives St. Louis-based Canopy an international reach Article by David Nicklaus Expanding internationally, being backed by a prominent private equity firm and tripling in size […]

Read More

Backed by Atlas Venture, BioGenerator Company Indalo Therapeutics Begins Clinical Program

Apr 18, 2019

Indalo Therapeutics Initiates Dosing in Phase 1 Clinical Trial of Lead Antifibrotic Drug Candidate IDL-2965  – Oral integrin antagonist inhibits multiple processes of pathologic fibrosis – Indalo to present at […]

Read More

Job Opening (BioSTL) — Professional to Lead Advancement

Apr 04, 2019

Position Summary: Reporting to the President and CEO, this senior advancement professional is responsible for all outcomes and activities associated with fundraising and donor relations with private donors, corporations, foundations, […]

Read More

BioGenerator Company Arch Oncology Closes $50M Series B to Develop Best in Class Anti-CD-47 Therapies

Mar 25, 2019

BRISBANE, Calif. and ST. LOUIS–(BUSINESS WIRE)–Arch Oncology, Inc., a clinical-stage immuno-oncology company focused on the discovery and development of best-in-class anti-CD47 antibody therapies, today announced a successful $50 million Series […]

Read More

BioGenerator Company Benson Hill Biosystems Continues Rapid Growth by Acquiring Schillinger Genetics

Mar 19, 2019

ST. LOUIS, MO—March 19, 2019—Benson Hill Biosystems, a crop improvement company unlocking the natural diversity of plants, announced today at the World Agri-Tech Innovation Summit that it has acquired the […]

Read More

Vaccine Breakthrough Published in Nature Communications Highlights Research of Startup VaxNewMo

Feb 21, 2019

BioGenerator-supported startup noted for its ‘promising process’ to more quickly and affordably bring vaccines to market   St. Louis bioscience startup VaxNewMo is developing broader and more affordable vaccines faster with […]

Read More

BioGenerator Company Arch Oncology Doses First Cancer Patient in Phase 1 Clinical Trial

Feb 06, 2019

Arch Oncology Announces First Patient Dosed in Phase 1 Clinical Trial of AO-176, an Anti-CD47 Antibody with a Best-in-class Profile — Phase 1 Clinical Trial to Evaluate AO-176 for the […]

Read More

BioGenerator and Bayer Growth Ventures Lead Financing for Agtech Startup CoverCress

Nov 14, 2018

Arvegenix Changes Name to CoverCress Inc.;  Secures $2 Million in New Financing for Novel Crop Development  ST. LOUIS (Nov. 14, 2018) – CoverCress Inc. (formerly Arvegenix Inc.), recently closed a $2 […]

Read More

Latest Tweets

Getting Started

Entrepreneurs Investors